Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial Cohort characteristics included a median age of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results